Companies Should Research Health Care Products For Use in Developing Na

Companies Should look for Health C are Products For Use in Developing NationsThe industry of health check look and product development is an expensive and risky business in which the rate of failure far outweighs the likelihood of success (Glaxo). Only the largest companies sack afford to invest large amounts of time and capital in projects that expect to permit little chance of striking research gold--a drug that is effective, safe, and vendible for a profit. This creates an writ large problem what incentives exist that would encourage companies to make a commitment to the development and distribution of products that are not likely to arouse great returns, namely medicines that would be used mainly in ternion world countries? Are these companies mor anyy obligated to earmark at to the lowest degree some of their profits to pursue such projects? What responsibilities do the brasss of developing nations have to their citizens in providing and improving health care? Some o f the close to pressing current health issues in developing countries are the threats posed by drug-resistant TB and malaria, Hepatitis A and B, yellow fever, meningococcal meningitis, and typhoid fever (Alameda). Vaccines are operable for all of the above infections except TB and malaria, but separate injections are required for each, some require follow-ups, and each injection costs as much as $75 (Alameda). This is an expense that is obviously not hard-nosed for most rural citizens in Africa and Southeast Asia, some of the areas where these diseases are most prevalent (Glaxo). No relief effort to date has the resources to make general distribution of these vaccines possible or practical. The very beginning of the battle is do products that will greatly increase the health o... ...of companies with the resources who would enjoy the benefits. In addition, it is obvious that the US on an international scale benefits from such efforts, and thus our government should be willing t o support or conduct such research when necessary. Works CitedAlameda Travel Vaccination Center. About the Vaccines Alameda Travel Vaccination Center. http www.netcantina.com/travelmed/homepage/.htm (6 border district 1997). Belden, Peter. US Agency for International Development. Letter to the author. 8 March 1997. Glaxo Wellcome Inc. A Timely, Two-Sided Attack on Malaria, Glaxo Wellcome Noticeboard, Glaxo Wellcome Research Centres. Glaxo Wellcome http//www.glaxowellcome.co.uk/netscape/world contains links to all articles (6 March 1997). Smallpox. Encyclopedia Britannica. vol. 10, 1994 ed. p. 887-8. Ryan, Dr. Thomas E. Physician. Letter to the author. 8 Mar 1997.